[go: up one dir, main page]

CN101906408B - Enzyme preparation for synthesizing D-aryl glycine through biocatalysis and preparation method and application thereof - Google Patents

Enzyme preparation for synthesizing D-aryl glycine through biocatalysis and preparation method and application thereof Download PDF

Info

Publication number
CN101906408B
CN101906408B CN2010101813858A CN201010181385A CN101906408B CN 101906408 B CN101906408 B CN 101906408B CN 2010101813858 A CN2010101813858 A CN 2010101813858A CN 201010181385 A CN201010181385 A CN 201010181385A CN 101906408 B CN101906408 B CN 101906408B
Authority
CN
China
Prior art keywords
arylglycine
enzyme
enzyme preparation
weight
glycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2010101813858A
Other languages
Chinese (zh)
Other versions
CN101906408A (en
Inventor
刘守信
李军章
甄小丽
田霞
明常鑫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei University of Science and Technology
Original Assignee
Hebei University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei University of Science and Technology filed Critical Hebei University of Science and Technology
Priority to CN2010101813858A priority Critical patent/CN101906408B/en
Publication of CN101906408A publication Critical patent/CN101906408A/en
Application granted granted Critical
Publication of CN101906408B publication Critical patent/CN101906408B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention relates to an enzyme preparation for synthesizing D-aryl glycine through biocatalysis, which consists of activated cells of arthrobacter aurescens producing hydantoinase and activated cells of agrobacterium radiobacter producing carbamoylase. The invention also relates to a preparation method and application of the enzyme preparation for synthesizing the D-aryl glycine through the biocatalysis. The enzyme preparation can be used for synthesizing the D-aryl glycine or derivatives thereof through the catalysis of heterogeneous hydrolysis of hydantoin. Through the enzyme preparation, the production cost is reduced greatly and the yield of products is improved.

Description

生物催化合成D-芳基甘氨酸的酶制剂及其制备方法和应用Enzyme preparation for biocatalytic synthesis of D-arylglycine and its preparation method and application

技术领域 technical field

本发明属于微生物发酵领域,特别涉及一种生物催化合成D-芳基甘氨酸的酶制剂及其制备方法和应用。The invention belongs to the field of microbial fermentation, and in particular relates to an enzyme preparation for biocatalytically synthesizing D-arylglycine, a preparation method and application thereof.

背景技术 Background technique

D-芳基氨基酸(如,D-芳基甘氨酸)是一类十分重要的非天然氨基酸,由于其构型与天然氨基酸正好相反而可以用于药物(如,拮抗剂)、肽以及甜味剂等的合成和制备,近年来随着对其应用价值的进一步开发,市场的需求量在迅猛增长。D-aryl amino acids (e.g., D-arylglycine) are a very important class of unnatural amino acids, which can be used in drugs (e.g., antagonists), peptides, and sweeteners due to their configuration opposite to natural amino acids In recent years, with the further development of its application value, the demand of the market is growing rapidly.

传统的D-芳基氨基酸(如,D-芳基甘氨酸)的制备方法,包括了化学合成及拆分法,但是其需要浪费一半的对映异构体,造成生产效率低、产能低、能耗高等缺点。The traditional preparation method of D-aryl amino acid (such as D-arylglycine) includes chemical synthesis and resolution, but it needs to waste half of the enantiomers, resulting in low production efficiency, low production capacity, energy Disadvantages such as high consumption.

在生物催化D-芳基海因水解法中,传统的技术为“一菌两酶”法,如中国专利或专利申请01105347、200710191968等所述的。但是,该技术中所使用的一种微生物本身要兼顾两种酶,难以耐受高浓度的底物并在工业生产中保持连续的酶催化作用,因此难以加入饱和浓度的底物而实现非均相酶催化。因此这些专利申请即使授权,也因不适合实际的工业生产而放弃了专利权。In the biocatalytic D-aryl hydantoin hydrolysis method, the traditional technology is the "one bacterium, two enzymes" method, as described in Chinese patents or patent applications 01105347, 200710191968, etc. However, a microorganism used in this technology has to take care of two kinds of enzymes, it is difficult to tolerate high concentrations of substrates and maintain continuous enzyme catalysis in industrial production, so it is difficult to add saturated concentrations of substrates to achieve non-uniformity. Phase enzyme catalysis. Therefore, even if these patent applications are authorized, the patent rights have been abandoned because they are not suitable for actual industrial production.

中国专利申请200610048209.0和200710062118.7公开了一种非均相酶催化水解5-芳基海因合成D-芳基甘氨酸或其衍生物的方法,以“两菌两酶”法来代替传统的“一菌两酶”法,其中使用黄金节杆菌(Arthrobacter aurescens)LZ98或其突变菌UV-LZ98来产生海因酶(Hydantoinase)并使用放射形土壤杆菌(Agrobacterium radiobacter)LZ99或其突变菌UV-LZ99来产生氨甲酰胺水解酶,由此产生一定酶活性的酶制剂来使得相应合成方法得以实现。然而,该方法中使用的制备酶制剂的两株菌株购买成本较高,尤其是LZ99以及突变菌UV-LZ99不但昂贵,而且产生的氨甲酰胺水解酶在工业规模的长时间发酵时稳定性不够,发酵耐久性不足,大大限制了该专利的非均相酶催化水解5-芳基海因来合成D-芳基甘氨酸的工业化应用。Chinese patent applications 200610048209.0 and 200710062118.7 disclose a method for synthesizing D-arylglycine or its derivatives by catalyzing the hydrolysis of 5-arylhydantoin by heterogeneous enzymes, using the "two bacteria and two enzymes" method to replace the traditional "one bacteria Two-enzyme method, wherein Arthrobacter aurescens LZ98 or its mutant strain UV-LZ98 is used to produce Hydantoinase and Agrobacterium radiobacter LZ99 or its mutant strain UV-LZ99 is used to produce Carbamidohydrolase, thereby producing an enzyme preparation with certain enzyme activity to enable the corresponding synthesis method to be realized. However, the purchase cost of the two bacterial strains used to prepare the enzyme preparations used in this method is relatively high, especially LZ99 and the mutant strain UV-LZ99 are not only expensive, but also the carbamidohydrolase produced is not stable enough for long-term fermentation on an industrial scale , The lack of fermentation durability greatly limits the industrial application of the patented heterogeneous enzyme catalyzed hydrolysis of 5-arylhydantoin to synthesize D-arylglycine.

发明内容 Contents of the invention

本发明为克服现有技术中存在的问题,提供一种生物催化合成D-芳基甘氨酸的酶制剂及其制备方法和应用,它能代替现有的用于非均相酶催化水解5-芳基海因制备D-芳基甘氨酸的方法中的酶制剂,使生产成本大大降低,且方法简单、易于工业化应用。In order to overcome the problems in the prior art, the present invention provides an enzyme preparation for the biocatalytic synthesis of D-arylglycine and its preparation method and application. The enzyme preparation in the method for preparing D-arylglycine by Genehydine greatly reduces the production cost, and the method is simple and easy for industrial application.

本发明采用以下技术方案予以实现:The present invention adopts following technical scheme to realize:

本发明的第一个方面,生物催化合成D-芳基甘氨酸的酶制剂,它由产海因酶的黄金节杆菌的活化细胞和产氨甲酰水解酶的放射形土壤杆菌的活化细胞组成。The first aspect of the present invention is an enzyme preparation for biocatalytically synthesizing D-arylglycine, which consists of activated cells of Arthrobacter aureus producing hydantoinase and activated cells of Agrobacterium radiata producing carbamoylase.

所述的生物催化合成D-芳基甘氨酸的酶制剂,其特征是,所述黄金节杆菌产生的海因酶的初始酶活性为大于0.32U,所述放射形土壤杆菌产生的氨甲酰水解酶的初始的活性大于10U。The enzyme preparation for the biocatalytic synthesis of D-arylglycine is characterized in that the initial enzyme activity of the hydantoinase produced by the Arthrobacter aureus is greater than 0.32 U, and the carbamoyl hydrolysis produced by the Agrobacterium radialis The initial activity of the enzyme is greater than 10U.

所述的生物催化合成D-芳基甘氨酸的酶制剂,所述黄金节杆菌的初始海因酶活性为0.32U~0.45U。In the enzyme preparation for the biocatalytic synthesis of D-arylglycine, the initial hydantoinase activity of Arthrobacter aureus is 0.32U-0.45U.

所述的生物催化合成D-芳基甘氨酸的酶制剂,所述黄金节杆菌为黄金节杆菌3256活化细胞,所述放射形土壤杆菌为放射形土壤杆菌3255活化细胞。In the enzyme preparation for biocatalyzing the synthesis of D-arylglycine, the Arthrobacter aureus is the activated cell of Arthrobacter aureus 3256, and the Agrobacterium radialis is the activated cell of Agrobacterium radialis 3255.

本发明的第二个方面,所述的生物催化合成D-芳基甘氨酸的酶制剂的制备方法,它包括以下步骤:In a second aspect of the present invention, the preparation method of the enzyme preparation for the biocatalytic synthesis of D-arylglycine comprises the following steps:

a.将产海因酶的黄金节杆菌接种于含玉米浆、糖蜜、氢氧化钠水溶液、氯化钠、2-硫尿嘧啶、硫酸镁、硫酸锰和磷酸氢二铵的液体培养基中,于30~34℃搅拌活化培养。其中,搅拌速度为60rpm,活化时间为12~18h,优选14~16h;空气压力为0.18~0.23Mpa,优选为0.2Mpa;空气流量为20~26L/h;反应釜压力为0.04~0.06Mpa,优选为0.05Mpa;然后将该培养液用壳聚糖水溶液絮凝,过滤收获固形酶制剂1;a. inoculate the Arthrobacter aureus producing hydantoinase in the liquid culture medium containing corn steep liquor, molasses, aqueous sodium hydroxide solution, sodium chloride, 2-thiouracil, magnesium sulfate, manganese sulfate and diammonium hydrogen phosphate, Stir and activate the culture at 30-34°C. Among them, the stirring speed is 60rpm, the activation time is 12-18h, preferably 14-16h; the air pressure is 0.18-0.23Mpa, preferably 0.2Mpa; the air flow is 20-26L/h; the reactor pressure is 0.04-0.06Mpa, It is preferably 0.05Mpa; then the culture fluid is flocculated with chitosan aqueous solution, and the solid enzyme preparation 1 is harvested by filtration;

所述液体培养基含玉米浆360~460重量份、糖蜜380~480重量份、浓度为25~35%(w/w)的氢氧化钠水溶液15~25重量份、氯化钠40~60重量份、2-硫尿嘧啶27~37重量份硫酸镁8~10重量份、硫酸锰1.2~1.8重量份和磷酸氢二铵3~4重量份,并加水定容至8000重量份;The liquid medium contains 360-460 parts by weight of corn steep liquor, 380-480 parts by weight of molasses, 15-25 parts by weight of aqueous sodium hydroxide solution with a concentration of 25-35% (w/w), and 40-60 parts by weight of sodium chloride. 27-37 parts by weight of 2-thiouracil, 8-10 parts by weight of magnesium sulfate, 1.2-1.8 parts by weight of manganese sulfate and 3-4 parts by weight of diammonium hydrogen phosphate, and add water to make the volume to 8000 parts by weight;

b.将产氨甲酰水解酶的放射形土壤杆菌接种于含玉米浆、葡萄糖、蛋白胨、氯化钠、硫酸锰、磷酸氢二铵和阿拉伯糖的液体培养基中,于32~38℃搅拌活化培养,其中搅拌速度为60rpm;活化时间为15~22h,优选16~18h,最优选为17h;空气压力为0.18~0.23Mpa,优选为0.2Mpa;空气流量为18~22L/h;反应釜压力为0.04~0.06Mpa,优选为0.05Mpa;在所述培养基中添加氢氧化钠调节pH为6.5~7.8,优选为6.8~7.3,最优选为7.0,然后将该培养液用壳聚糖水溶液絮凝,过滤收获固形酶制剂2;b. Inoculate Agrobacterium radiata producing carbamoylase in a liquid medium containing corn steep liquor, glucose, peptone, sodium chloride, manganese sulfate, diammonium hydrogen phosphate and arabinose, and stir at 32-38°C Activation culture, wherein the stirring speed is 60rpm; the activation time is 15-22h, preferably 16-18h, most preferably 17h; the air pressure is 0.18-0.23Mpa, preferably 0.2Mpa; the air flow is 18-22L/h; The pressure is 0.04~0.06Mpa, preferably 0.05Mpa; adding sodium hydroxide to the medium to adjust the pH is 6.5~7.8, preferably 6.8~7.3, most preferably 7.0, and then the culture solution is treated with chitosan aqueous solution Flocculation, filtering and harvesting solid enzyme preparation 2;

所述液体培养基含玉米浆200~400重量份、葡萄糖180~260重量份、蛋白胨80~100重量份、25g氯化钠20~30重量份、硫酸锰1.6~2.0重量份、磷酸氢二铵6.8~7.6重量份和阿拉伯糖12~16重量份;并将所述液体培养基加水定容至8000重量份;The liquid medium contains 200-400 parts by weight of corn steep liquor, 180-260 parts by weight of glucose, 80-100 parts by weight of peptone, 20-30 parts by weight of 25g sodium chloride, 1.6-2.0 parts by weight of manganese sulfate, diammonium hydrogen phosphate 6.8 to 7.6 parts by weight and 12 to 16 parts by weight of arabinose; adding water to the liquid medium to make up to 8000 parts by weight;

c.将步骤a制得的固形酶制剂1和步骤b制得的固形酶制剂2混合,制得生物催化合成D-芳基甘氨酸的酶制剂。其中所述固形酶制剂1和所述固形酶制剂2的重量配比随底物的不同而有所不同,通常控制二者比例为1~5∶1~50,优选的比例为1~5∶1~20,更优选的比例为1~2∶1~5。c. Mix the solid enzyme preparation 1 prepared in step a and the solid enzyme preparation 2 prepared in step b to prepare an enzyme preparation for biocatalytically synthesizing D-arylglycine. Wherein the weight ratio of the solid enzyme preparation 1 and the solid enzyme preparation 2 varies with the substrate, usually the ratio of the two is controlled to be 1~5:1~50, and the preferred ratio is 1~5: 1-20, the more preferred ratio is 1-2:1-5.

本发明的第三个方面,所述的生物催化合成D-芳基甘氨酸的酶制剂,它用于酶催化非均相水解海因合成D-芳基甘氨酸的方法中。In the third aspect of the present invention, the enzyme preparation for biocatalytically synthesizing D-arylglycine is used in the method for enzymatically catalyzing heterogeneous hydrolysis of hydantoin to synthesize D-arylglycine.

所述的酶催化非均相水解海因合成D-芳基甘氨酸的方法包括以下步骤:The method for the synthesis of D-arylglycine by the enzyme-catalyzed heterogeneous hydrolysis of hydantoin comprises the following steps:

①酶催化反应罐中,加入水和5-芳基海因,并调整pH值为6.5~7.8,芳基海因的加入量占水和5-芳基海因总重量的5~21%(w/w),得混合溶液;①In the enzyme-catalyzed reaction tank, add water and 5-arylhydantoin, and adjust the pH value to 6.5-7.8, and the addition of arylhydantoin accounts for 5-21% of the total weight of water and 5-arylhydantoin ( w/w), to obtain a mixed solution;

在步骤①中,由此配比的物料将形成悬浊液,即溶液呈过饱和状态,有5-芳基海因的固体原料存在。In step ①, the materials thus proportioned will form a suspension, that is, the solution is in a supersaturated state, and there are solid raw materials of 5-arylhydantoin.

②在搅拌的条件下向酶催化反应罐中加入权利要求1~5任一所述的生物催化合成D-芳基甘氨酸的酶制剂,在25~40℃下搅拌反应,直至无法检测出5-芳基海因,得D-芳基甘氨酸;② Add the enzyme preparation for the biocatalytic synthesis of D-arylglycine according to any one of claims 1 to 5 into the enzyme-catalyzed reaction tank under stirring conditions, and stir the reaction at 25-40°C until 5-arylglycine cannot be detected. Aryl hydantoin, get D-aryl glycine;

其中所述生物催化合成D-芳基甘氨酸的酶制剂占步骤①中的混合溶液的总重量的1~10%,优选为为2-8%;反应时间8~66小时;The enzyme preparation for the biocatalytic synthesis of D-arylglycine accounts for 1-10% of the total weight of the mixed solution in step ①, preferably 2-8%; the reaction time is 8-66 hours;

③通过200目筛分离出D-芳基甘氨酸固体,经过重结晶,获得D-芳基甘氨酸晶体;③ Separating the D-arylglycine solid through a 200-mesh sieve, and obtaining D-arylglycine crystals through recrystallization;

在步骤③中,由于存在菌体和细小的固体产品结晶,因此优选通过200目筛分离,所截留下来的固体是粒度较大的D-芳基甘氨酸晶体(粗产品),菌体和碎小颗粒的固体产物通过筛孔而进入到膜分离系统。In step ③, due to the presence of thalline and tiny solid product crystals, it is preferably separated by a 200 mesh sieve, and the intercepted solid is larger D-arylglycine crystals (crude product), thallus and broken small The granular solid product enters the membrane separation system through the mesh.

④通过截留5000~5万分子量超滤膜过滤和蒸发浓缩来提取酶催化反应溶液中溶解的D-芳基甘氨酸,再经过重结晶,得D-芳基甘氨酸晶体。④ Extract the D-arylglycine dissolved in the enzyme-catalyzed reaction solution by ultrafiltration with a molecular weight cut-off of 5,000 to 50,000 and evaporation concentration, and then recrystallize to obtain D-arylglycine crystals.

由于分离出D-芳基甘氨酸晶体后所得的溶液是饱和的D-芳基甘氨酸,为了进一步提高产率,因此采用了步骤④。即将步骤③能流过筛的液体通过膜过滤除去菌体,对滤液浓缩得到D-芳基甘氨酸晶体,经过重结晶,获得D-芳基甘氨酸晶体。Since the solution obtained after the separation of D-arylglycine crystals is saturated D-arylglycine, in order to further increase the yield, step ④ was adopted. That is, the liquid that can flow through the sieve in step ③ is filtered through a membrane to remove bacteria, and the filtrate is concentrated to obtain D-arylglycine crystals, which are recrystallized to obtain D-arylglycine crystals.

优选的,所述的非均相酶催化水解海因合成D-芳基甘氨酸的方法步骤④还可以采用以下步骤:Preferably, the method step ④ of the heterogeneous enzyme catalyzed hydrolysis of hydantoin to synthesize D-arylglycine can also adopt the following steps:

先通过超滤膜过滤筛分分离透过筛孔的部分,即得酶催化反应罐中溶解有D-芳基甘氨酸的溶液,其膜透析液被蒸发浓缩得另一部分D-芳基甘氨酸粗产品,再经重结晶获得D-芳基甘氨酸晶体。First pass through the ultrafiltration membrane to filter and sieve to separate the part that passes through the sieve holes, and then obtain the solution in which D-arylglycine is dissolved in the enzyme-catalyzed reaction tank, and the membrane dialysate is evaporated and concentrated to obtain another part of the crude product of D-arylglycine , and then recrystallized to obtain D-arylglycine crystals.

所述的非均相酶催化水解海因合成D-芳基甘氨酸的方法中的D-芳基甘氨酸为D-苯甘氨酸、D-对羟基苯甘氨酸、D-氟苯甘氨酸、D-氯苯甘氨酸、D-溴苯甘氨酸、D-碘苯甘氨酸、D-甲氧苯甘氨酸、D-吡啶系列甘氨酸、D-萘系列甘氨酸、D-喹啉系列甘氨酸D-嘧啶甘氨酸、D-吡嗪甘氨酸、D-哒嗪甘氨酸、D-吲哚甘氨酸、D-噻吩甘氨酸、D-呋喃甘氨酸、D-吡咯甘氨酸、D-吡唑甘氨酸、D-咪唑甘氨酸、D-噻唑甘氨酸、D-噁唑甘氨酸和D-异噁唑甘氨酸中的一种。The D-arylglycine in the method for the synthesis of D-arylglycine by the heterogeneous enzyme catalyzed hydrolysis hydantoin is D-phenylglycine, D-p-hydroxyphenylglycine, D-fluorophenylglycine, D-chlorophenylglycine , D-bromophenylglycine, D-iodophenylglycine, D-methoxyphenylglycine, D-pyridine series glycine, D-naphthalene series glycine, D-quinoline series glycine D-pyrimidine glycine, D-pyrazine glycine, D -pyridazine glycine, D-indole glycine, D-thiophene glycine, D-furan glycine, D-pyrrole glycine, D-pyrazole glycine, D-imidazole glycine, D-thiazole glycine, D-oxazole glycine and D- One of the isoxazole glycine.

进一步的,所述制备非均相酶催化水解海因合成D-芳基甘氨酸的方法中的D-芳基甘氨酸为D-苯甘氨酸;所述D-苯甘氨酸的制备方法为:Further, the D-arylglycine in the method for preparing D-arylglycine by catalyzing the hydrolysis of hydantoin by heterogeneous enzymes is D-phenylglycine; the preparation method of D-phenylglycine is:

①在酶催化反应罐中,加入水30kg和5-苯基海因2.8kg,并调整pH值为6.8;①In the enzyme-catalyzed reaction tank, add 30kg of water and 2.8kg of 5-phenylhydantoin, and adjust the pH value to 6.8;

②在搅拌的条件下向酶催化反应罐加入权利要求1-5之任一所述的生物催化合成D-芳基甘氨酸的酶制剂2.8kg,在38℃下搅拌反应,直至无法检测出5-苯基海因,并且中间产物N-氨甲酰苯甘氨酸含量小于等于0.25%(w/w),显示反应基本完成,制得D-苯基甘氨酸;2. Add 2.8kg of the enzyme preparation for biocatalytic synthesis of D-arylglycine according to any one of claims 1-5 to the enzyme catalytic reaction tank under stirring conditions, and stir and react at 38°C until 5-arylglycine cannot be detected. Phenylhydantoin, and the content of the intermediate product N-carbamoylglycine is less than or equal to 0.25% (w/w), indicating that the reaction is basically completed and D-phenylglycine is obtained;

③分离析出D-苯基甘氨酸固体,经过重结晶,获得D-苯基甘氨酸晶体产品;③ Separation and precipitation of D-phenylglycine solid, after recrystallization, D-phenylglycine crystal product is obtained;

④通过超滤膜过滤和蒸发浓缩来提取酶催化反应溶液中溶解的D-苯基甘氨酸,得另一部分,即D-苯基甘氨酸产品。④ Extract the D-phenylglycine dissolved in the enzyme-catalyzed reaction solution through ultrafiltration membrane filtration and evaporation concentration to obtain another part, namely the D-phenylglycine product.

在所述生物催化合成D-芳基甘氨酸的酶制剂中,所述黄金节杆菌和放射形土壤杆菌均为活菌,优选为活化培养的菌。因此,优选本发明第一方面提供的生物催化合成D-芳基甘氨酸的酶制剂是由产海因酶的黄金节杆菌的活化细胞和产氨甲酰水解酶的放射形土壤杆菌的活化细胞组成。在本发明中,“活化细胞”表示菌体细胞经过活化培养,使得细胞具有相应的纯化形式的酶的酶活性,即海因酶活性和氨甲酰水解酶活性。因此,所述生物催化合成D-芳基甘氨酸的酶制剂可以在工业化生产过程中保持长时间的酶活性。尽管所述的生物催化合成D-芳基甘氨酸的酶制剂是不可溶的(包括菌体),但是根据本发明人长期观察,配合使用本发明所述的非均相法制备的D-芳基甘氨酸的粗晶体颗粒比菌体及其碎片大得多,因此可以容易地通过过筛分离的方法提取粗晶体颗粒,而不会引入过多菌体杂质以影响纯度,也不会分离丧失掉粗晶体颗粒而导致产率下降。In the enzyme preparation for biocatalytically synthesizing D-arylglycine, both the Arthrobacter aureus and the Agrobacterium radiata are live bacteria, preferably activated cultured bacteria. Therefore, it is preferred that the enzyme preparation for the biocatalytic synthesis of D-arylglycine provided by the first aspect of the present invention is composed of the activated cells of Arthrobacter aureus producing hydantoinase and the activated cells of Agrobacterium radiata producing carbamoylase . In the present invention, "activated cells" means that the bacterial cells have been activated and cultured, so that the cells have the corresponding enzymatic activities of purified enzymes, namely hydantoinase activity and carbamoylase activity. Therefore, the enzyme preparation for biologically catalyzing the synthesis of D-arylglycine can maintain long-term enzyme activity during industrial production. Although the enzyme preparation for the biocatalytic synthesis of D-arylglycine is insoluble (including bacteria), according to the long-term observation of the inventors, the D-aryl The crude crystal particles of glycine are much larger than the bacteria and its fragments, so the crude crystal particles can be easily extracted by sieving and separation without introducing too much bacteria impurities to affect the purity, and will not lose the crude Crystal particles lead to a decrease in yield.

在本发明的第一方面中,黄金节杆菌的初始海因酶活性为大于0.30U,放射形土壤杆菌的初始氨甲酰水解酶为大于9U,优选初始海因酶活性为大于0.32U,也优选初始氨甲酰水解酶为大于10U,最佳选初始氨甲酰水解酶为9.5U~15U,最佳选初始氨甲酰水解酶为10U~12U。由于在工业化生产过程中,酶的活性会逐渐降低。因此,本发明的第一方面中的菌体本身需要有一定催化能力,而且该催化能力需要在工业化生产中定量可控的。这样,本发明使用活化后投料前针对菌体测定的初始活性作为催化能力指标,其具体测量方法可以根据本发明具体实施例中所列的方式进行。本发明人发现,由于改用了产氨甲酰水解酶的放射形土壤杆菌,催化效率和稳定性得以提高,中间产物积累少,因此产海因酶的黄金节杆菌无需太好,其初始海因酶活性可以优选为0.32~0.45U。这样,可以使用市售的较便宜的黄金节杆菌,如黄金节杆菌3256。另外,由于产氨甲酰水解酶的放射形土壤杆菌筛选较容易,因此可以不使用昂贵的LZ系列菌种,而使用较便宜的市售放射形土壤杆菌,如放射形土壤杆菌3255。在本发明的具体实施方式中,优选的酶制剂由放射形土壤杆菌3255和黄金节杆菌3256组成,更优选的酶制剂由放射形土壤杆菌3255活化细胞和黄金节杆菌3256活化细胞组成。In the first aspect of the present invention, the initial hydantoinase activity of Arthrobacter aureus is greater than 0.30U, the initial carbamoylase activity of Agrobacterium radiatus is greater than 9U, preferably the initial hydantoinase activity is greater than 0.32U, also The preferred initial carbamoylase is greater than 10U, the optimal initial carbamoylase is 9.5U-15U, and the most optimal initial carbamoylase is 10U-12U. Due to the industrial production process, the activity of the enzyme will gradually decrease. Therefore, the bacteria in the first aspect of the present invention need to have a certain catalytic ability, and the catalytic ability needs to be quantitatively controllable in industrial production. In this way, the present invention uses the initial activity measured for the bacteria after activation and before feeding as an index of catalytic ability, and its specific measurement method can be carried out according to the methods listed in the specific examples of the present invention. The inventors have found that the catalytic efficiency and stability of Agrobacterium radiatus have been changed to produce carbamoylase, and the accumulation of intermediate products is less. Therefore, the Arthrobacter aureus producing hydantoinase does not need to be too good. Due to enzyme activity, it can be preferably 0.32 to 0.45 U. In this way, commercially available less expensive Arthrobacter aureus, such as Arthrobacter aureus 3256, can be used. In addition, since the screening of carbamoylase-producing Agrobacterium radiatus is easier, the expensive LZ series strains can be used instead of the cheaper commercially available Agrobacterium radiatus, such as Agrobacterium radiatus 3255. In a specific embodiment of the present invention, the preferred enzyme preparation is composed of Agrobacterium radialis 3255 and Arthrobacter aureus 3256, and the more preferred enzyme preparation is composed of Agrobacterium radialis 3255 activated cells and Arthrobacter aureus 3256 activated cells.

为了进一步改进现有技术中的缺陷,我们经过艰苦实验,发现当使用适当活化培养的菌株细胞直接配制本发明的生物催化合成D-芳基甘氨酸的酶制剂的时候(即采用本发明的“两菌”法),其中即使采用了更为常规的氨甲酰水解酶(Carbamylase)代替现有“两菌两酶”法中的氨甲酰胺水解酶,也能够满足非均相酶催化水解5-芳基海因合成D-芳基甘氨酸的需求,因此可以不使用诸如突变菌UV-LZ99等昂贵的菌株来提取相应的氨甲酰胺水解酶,从而最终配制成生物催化合成D-芳基甘氨酸的酶制剂。更令人意想不到的是,当采用本发明的方法活化菌株细胞并配制生物催化合成D-芳基甘氨酸的酶制剂,甚至海因酶的产生菌株也可以使用较为常规而且价格更为低廉的菌株。以上菌株的使用在降低成本的同时,并不影响工业规模的酶催化非均相水解5-芳基海因合成D-芳基甘氨酸的稳定性以及耐久性,也可以直接使用原有非均相酶催化的设备以及发酵流程,无需新的设备成本投入,也无需重新培训生产线上的技术人员以掌握其他发酵流程。In order to further improve the deficiencies in the prior art, we have found through hard experiments that when using properly activated and cultured strain cells to directly prepare the enzyme preparation for the biocatalytic synthesis of D-arylglycine of the present invention (i.e. using the "two" of the present invention Bacteria" method), even if the more conventional carbamylase (Carbamylase) is used to replace the carbamylase in the existing "two bacteria and two enzymes" method, it can also meet the requirements of heterogeneous enzyme catalyzed hydrolysis of 5- Arylhydantoin needs to synthesize D-arylglycine, so expensive strains such as mutant bacteria UV-LZ99 can be used to extract the corresponding carbamidohydrolase, and finally formulated as a biocatalytic synthesis of D-arylglycine Enzyme. What is even more unexpected is that when the method of the present invention is used to activate the strain cells and prepare the enzyme preparation for the biocatalytic synthesis of D-arylglycine, even the hydantoinase production strain can use more conventional and cheaper strains. The use of the above strains reduces the cost and does not affect the stability and durability of the industrial-scale enzyme-catalyzed heterogeneous hydrolysis of 5-arylhydantoin to synthesize D-arylglycine, and the original heterogeneous phase hydrolysis can also be used directly. Enzyme-catalyzed equipment and fermentation processes do not require investment in new equipment costs, and there is no need to retrain technicians on the production line to master other fermentation processes.

本发明与现有技术相比具有的有益效果为:The beneficial effect that the present invention has compared with prior art is:

①与原有“两菌两酶”法在非均相酶催化水解5-芳基海因合成D-芳基甘氨酸中应用相比,本发明换用了酶并换用了活化和配制方法,本发明反应速度快、节能、产率高、产品质量稳定等。① Compared with the application of the original "two bacteria and two enzymes" method in the synthesis of D-arylglycine by the heterogeneous enzyme catalyzed hydrolysis of 5-arylhydantoin, the present invention uses the enzyme and the activation and preparation method instead, The invention has the advantages of fast reaction speed, energy saving, high yield, stable product quality and the like.

②“两菌”法无需提取酶的步骤,酶(菌)的活化过程与菌种细胞的培养放大过程合二为一,简化了实际生产的步骤,降低了生产成本。②The "two bacteria" method does not need the step of extracting enzymes, and the activation process of enzymes (bacteria) and the cultivation and amplification process of bacteria cells are combined into one, which simplifies the actual production steps and reduces the production cost.

③菌种成本低,无需多种昂贵的菌种相配合(即使海因酶的活性较低,也不影响最终发酵效率),而且新的活化和配制方法使得配制后得到的酶制剂在生产中持久、稳定,无需像“两酶两菌”法那样需要在长时间的反应过程中监控酶活性并适时补加,可以方便地放大到工业规模级的生产中,特别适于工业化生产。③ The cost of strains is low, and there is no need for a variety of expensive strains to cooperate (even if the activity of Hydantoinase is low, it will not affect the final fermentation efficiency), and the new activation and preparation methods make the enzyme preparations obtained after preparation in production It is durable and stable, and does not need to monitor the enzyme activity during the long-term reaction process and replenish it in a timely manner like the "two enzymes and two bacteria" method. It can be easily scaled up to industrial-scale production, and is especially suitable for industrial production.

④底物适应性强,无须像现有的“两菌两酶”法那样,D-对羟基苯甘氨酸可以使用放射形土壤杆菌LZ99发酵产生的酶,而对其他D-芳基甘氨酸则需要另外筛选出的放射形土壤杆菌UV-LZ99的酶。④ Strong substrate adaptability, no need for the existing "two bacteria and two enzymes" method, D-hydroxyphenylglycine can use the enzyme produced by the fermentation of Agrobacterium radiata LZ99, while other D-arylglycine requires additional The screened enzymes of Agrobacterium radialis UV-LZ99.

⑤直接使用了细胞而不使用可溶性酶,可以避免混合发酵以及酶提取的步骤,只需要活化菌种即可,对于长期困扰晶体纯度的蛋白杂质问题,我们经研究发现细胞体和用非均相法结晶出来的粗产物大小不同,用市售的200目筛就可以简单地分离,十分方便工业化生产。⑤ Directly using cells instead of soluble enzymes can avoid the steps of mixed fermentation and enzyme extraction, and only needs to activate the strains. For the problem of protein impurities that have long plagued crystal purity, we have found that cell bodies and heterogeneous phases The size of the crude product crystallized by the method is different, and it can be simply separated with a commercially available 200-mesh sieve, which is very convenient for industrial production.

具体实施方式 Detailed ways

下面结合具体实施例对本发明进行详细说明。The present invention will be described in detail below in conjunction with specific embodiments.

实施例一Embodiment one

1、海因酶制剂的制备1. Preparation of hydantoin enzyme preparation

在10L发酵罐中,分别加入416g玉米浆、428g糖蜜、20mL 30%(w/w)氢氧化钠水溶液、50g氯化钠、32g 2-硫尿嘧啶、10g硫酸镁、15g硫酸锰、3.6g磷酸氢二铵以及水至体积达到8L,于0.1~0.12Mpa压力、120~125℃条件下消毒灭菌0.5h,降温至30.5℃时,将预先在250mL摇瓶中培养好的黄金节杆菌3256(购自石家庄中天生物技术有限责任公司)接种于发酵罐中。随后在空气压力为0.2Mpa、空气流量为20~26L/h的前提下,控制反应釜压力为0.05Mpa、温度为33℃,搅拌发酵15h。然后,将发酵液用1%(w/w)壳聚糖400g絮凝,沉淀出含海因酶细胞,减压过滤得湿的海因酶制剂,即为活化的黄金节杆菌3256细胞。In a 10L fermenter, add 416g corn steep liquor, 428g molasses, 20mL 30% (w/w) sodium hydroxide aqueous solution, 50g sodium chloride, 32g 2-thiouracil, 10g magnesium sulfate, 15g manganese sulfate, 3.6g Diammonium hydrogen phosphate and water until the volume reaches 8L, sterilize at 0.1-0.12Mpa pressure, 120-125°C for 0.5h, and when the temperature is lowered to 30.5°C, Arthrobacter aureus 3256 that has been cultured in a 250mL shake flask in advance (purchased from Shijiazhuang Zhongtian Biotechnology Co., Ltd.) were inoculated in fermenters. Subsequently, under the premise of an air pressure of 0.2Mpa and an air flow rate of 20-26L/h, the pressure of the reactor was controlled to be 0.05Mpa and the temperature was 33°C, and the fermentation was stirred for 15h. Then, the fermented liquid was flocculated with 1% (w/w) chitosan 400g, and the hydantoinase-containing cells were precipitated, and the wet hydantoinase preparation was filtered under reduced pressure, which was activated Arthrobacter aureus 3256 cells.

同时,另外取1mL发酵液测定海因酶的酶活性:将1mL发酵液以4800r/min离心30min,弃上清液并将所得细胞重悬于生理盐水中,使总体积达到1mL,不提取酶而直接向该细胞悬液中加入9mL含2.2%(w/w)对羟基苯海因的磷酸缓冲溶液(pH8.0),于38℃下缓慢震荡反应30min,然后加入0.1mL 6N盐酸混匀终止反应,然后离心30min。取上清液,用HPLC测定其中D-N-氨甲酰对羟基苯甘氨酸的浓度。1个海因酶的酶活单位(U)被定义为每1min内每1mL发酵液所含细胞能产生的D-N-氨甲酰对羟基苯甘氨酸的量。根据三次发酵结果,海因酶活性分别为0.37U、0.42U和0.39U,表明用该方法可以直接稳定活化出高酶活性的细胞。At the same time, another 1 mL of fermentation broth was taken to measure the enzymatic activity of hydantoinase: centrifuge 1 mL of fermentation broth at 4800 r/min for 30 min, discard the supernatant and resuspend the obtained cells in normal saline to make the total volume reach 1 mL, without extracting the enzyme Add 9 mL of phosphate buffer solution (pH 8.0) containing 2.2% (w/w) p-hydroxyphenylhydantoin directly to the cell suspension, shake slowly at 38°C for 30 min, then add 0.1 mL of 6N hydrochloric acid and mix well The reaction was terminated, followed by centrifugation for 30 min. Take the supernatant, and measure the concentration of D-N-carbamoyl-p-hydroxyphenylglycine therein by HPLC. The enzyme activity unit (U) of 1 hydantinase is defined as the amount of D-N-carbamoyl-p-hydroxyphenylglycine that can be produced by cells contained in 1 mL of fermentation broth per 1 min. According to the results of three fermentations, hydantoin enzyme activities were 0.37U, 0.42U and 0.39U respectively, indicating that cells with high enzyme activity could be directly and stably activated by this method.

2、氨甲酰水解酶制剂的制备2. Preparation of carbamoylase preparations

在10L发酵罐中,分别加入360g玉米浆、220g葡萄糖、90g蛋白胨、25g氯化钠、1.8g硫酸锰、7.2g磷酸氢二铵、14g阿拉伯糖以及水至体积8L,并用氢氧化钠调节pH为6.8。于0.1~0.12Mpa压力、12.~125℃条件下消毒灭菌0.5h,降温至30.5℃,将预先在250mL摇瓶中培养好的放射形土壤杆菌3255(购自石家庄中天生物技术有限责任公司)接种于发酵罐中。随后在压力为0.2Mpa、空气流量为18~22L/h的前提下,控制反应釜压力0.05Mpa、温度为35℃,搅拌发酵17h。然后,将发酵液用1%(w/w)壳聚糖400g絮凝,从而沉淀出细胞,减压过滤得湿的氨甲酰水解酶制剂,即为活化的放射形土壤杆菌3255细胞In a 10L fermenter, add 360g corn steep liquor, 220g glucose, 90g peptone, 25g sodium chloride, 1.8g manganese sulfate, 7.2g diammonium hydrogen phosphate, 14g arabinose and water to a volume of 8L, and adjust the pH with sodium hydroxide is 6.8. Sterilize at 0.1-0.12Mpa pressure, 12.-125°C for 0.5h, cool down to 30.5°C, pre-cultivated Agrobacterium radialis 3255 in a 250mL shake flask (purchased from Shijiazhuang Zhongtian Biotechnology Co., Ltd. company) inoculated in the fermenter. Then, under the premise of a pressure of 0.2Mpa and an air flow rate of 18-22L/h, the pressure of the reactor was controlled at 0.05Mpa and the temperature was 35°C, and the fermentation was stirred for 17h. Then, the fermented liquid was flocculated with 1% (w/w) chitosan 400g to precipitate the cells, and the wet carbamoylase preparation obtained by filtration under reduced pressure was the activated Agrobacterium radialis 3255 cells

同时,另外取1mL发酵液测定氨甲酰水解酶的酶活性:将1mL发酵液以4800r/min离心30min,弃上清液并将所得细胞重悬于生理盐水中,使总体积达到1mL,不提取酶而直接向该细胞悬液中加入9mL含2.2%(w/w)D-N-氨甲酰对羟基苯甘氨酸的磷酸缓冲溶液(pH8.0),于38℃下缓慢震荡反应30min,然后加入0.1mL 6N盐酸混匀终止反应,然后离心30min。取上清液,用HPLC测定其中D-对羟基苯甘氨酸的浓度。1个氨甲酰水解酶的酶活单位(U)被定义为每1min内每1mL发酵液所含细胞能产生的D-对羟基苯甘氨酸的量。根据三次发酵结果,氨甲酰水解酶的酶活性分别为10.1U、11.7U和10.6U,表明用该方法可以直接稳定活化出高酶活性的细胞。At the same time, another 1 mL of fermentation broth was taken to measure the enzyme activity of carbamoyl hydrolase: 1 mL of fermentation broth was centrifuged at 4800 r/min for 30 min, the supernatant was discarded and the resulting cells were resuspended in normal saline to make the total volume reach 1 mL. To extract the enzyme, directly add 9 mL of phosphate buffer solution (pH 8.0) containing 2.2% (w/w) D-N-carbamoyl-p-hydroxyphenylglycine to the cell suspension, shake slowly at 38°C for 30 min, and then add Mix 0.1mL 6N hydrochloric acid to stop the reaction, and then centrifuge for 30min. Take the supernatant, and measure the concentration of D-p-hydroxyphenylglycine therein by HPLC. The enzyme activity unit (U) of 1 carbamoylase is defined as the amount of D-p-hydroxyphenylglycine that can be produced by cells contained in 1 mL of fermentation broth per 1 min. According to the results of three fermentations, the enzyme activities of carbamoylase were 10.1U, 11.7U and 10.6U respectively, indicating that cells with high enzyme activity could be stably activated directly by this method.

3,生物催化合成D-芳基甘氨酸的酶制剂3. Enzyme preparation for biocatalytic synthesis of D-arylglycine

取以上制备的湿的海因酶制剂和湿的氨甲酰水解酶制剂混合均匀,即得双酶制剂--生物催化合成D-芳基甘氨酸的酶制剂。The wet hydantoin enzyme preparation prepared above and the wet carbamoylase preparation are mixed evenly to obtain a double enzyme preparation—an enzyme preparation for biocatalytically synthesizing D-arylglycine.

实施例二,Embodiment two,

生物催化合成D-芳基甘氨酸的酶制剂的应用--催化反应实例Application of Enzyme Preparation for Biocatalytic Synthesis of D-Arylglycine--Catalyzed Reaction Example

1、D-对苯甘氨酸的制备1. Preparation of D-p-phenylglycine

在50L的酶催化反应罐中,先加入30kg水,然后投入5-苯基海因2.8kg,加盐酸或硫酸调整pH为6.8,在搅拌的条件下再加入由实施例一步骤1中制备的湿的海因酶制剂1.5kg和实施例一步骤2中制备的湿的氨甲酰水解酶酶制剂1.5kg,混合均匀,控制温度为38℃,搅拌反应。In a 50L enzyme-catalyzed reaction tank, first add 30kg of water, then put in 2.8kg of 5-phenylhydantoin, add hydrochloric acid or sulfuric acid to adjust the pH to 6.8, and then add the prepared by Example 1 step 1 under stirring conditions 1.5 kg of wet hydantoin enzyme preparation and 1.5 kg of wet carbamoylase enzyme preparation prepared in Step 2 of Example 1 were mixed uniformly, the temperature was controlled at 38° C., and the reaction was stirred.

当反应进行到4h左右时,则有D-苯甘氨酸晶体析出,其间抽样并用高效液相色谱检测反应,反应液中D-苯甘氨酸的浓度基本恒定在1.6%左右。待液相色谱几乎检不出底物5-苯基海因,且中间体N-氨甲酰苯甘氨酸含量低于0.25%时,停止反应。苯海因的转化率在99.6%以上。When the reaction lasted for about 4 hours, D-phenylglycine crystals were precipitated, during which time samples were taken and the reaction was detected by high-performance liquid chromatography. The concentration of D-phenylglycine in the reaction solution was basically constant at about 1.6%. When the substrate 5-phenylhydantoin can hardly be detected by liquid chromatography, and the content of the intermediate N-carbamoylglycine is lower than 0.25%, the reaction is stopped. The conversion rate of dihydantoin is above 99.6%.

对该50L酶催化反应罐中的物质过200目筛,以实现固体产物与微小的菌体细胞和溶液之间的分离,得到D-苯甘氨酸的粗晶体。以水为溶剂,通过酸碱转化重结晶便可获得D-苯甘氨酸1.48kg,此为第一部分产品;筛分分离得到的液体部分进一步提取:首先将液体通过截留5000分子量超滤膜进行过滤,滤液经减压蒸发浓缩,期间有D-苯甘氨酸结晶析出。过滤收集D-苯甘氨酸结晶,再采用第一部分产品相同的重结晶方法,便可获得第二部分产品0.51kg。合并两部分D-苯甘氨酸,共得纯度为99.8%以上、质量为1.99kg的产品,总收率83%。The material in the 50L enzyme-catalyzed reaction tank was passed through a 200-mesh sieve to separate the solid product from the tiny bacterial cells and the solution, and obtain crude crystals of D-phenylglycine. Using water as a solvent, 1.48kg of D-phenylglycine can be obtained through acid-base conversion and recrystallization, which is the first part of the product; the liquid part obtained by screening and separation is further extracted: first, the liquid is filtered through an ultrafiltration membrane with a molecular weight cut-off of 5000, The filtrate was concentrated by evaporation under reduced pressure, during which D-phenylglycine crystallized out. Collect D-phenylglycine crystals by filtration, and then use the same recrystallization method as the first part of the product to obtain the second part of product 0.51 kg. The two parts of D-phenylglycine were combined to obtain a product with a purity of more than 99.8% and a mass of 1.99 kg, with a total yield of 83%.

2,D-苯甘氨酸衍生物的制备2. Preparation of D-phenylglycine derivatives

采用与上述1D-对苯甘氨酸的制备相同的制备方法和参数,其中以5-对羟基苯海因4.5kg代替5-苯海因2.8kg,最终得到纯度为99.7%以上的D-对羟基苯甘氨酸晶体3.1kg。Using the same preparation method and parameters as the preparation of 1D-p-phenylglycine above, 4.5 kg of 5-p-hydroxyphenylhydantoin was used instead of 2.8 kg of 5-phenylhydantoin to finally obtain D-p-hydroxybenzene with a purity of more than 99.7%. Glycine crystals 3.1kg.

采用与上述1D-对苯甘氨酸的制备相同的制备方法和参数,其中以5-对甲氧基苯海因3.2kg代替5-苯海因2.8kg,最终得到纯度为99.8%以上的D-对甲氧基苯甘氨酸晶体2.3kg。Using the same preparation method and parameters as the preparation of 1D-p-phenylglycine above, 3.2 kg of 5-p-methoxyphenylhydantoin was used instead of 2.8 kg of 5-phenylhydantoin to finally obtain D-p-phenylglycine with a purity of more than 99.8%. Methoxyphenylglycine crystal 2.3kg.

采用与上述1D-对苯甘氨酸的制备相同的制备方法和参数,其中以5-对氟苯海因3.8kg代替5-苯海因2.8kg,最终得到纯度为99.8%以上的D-对氟苯甘氨酸晶体2.6kg。Using the same preparation method and parameters as the preparation of 1D-p-phenylglycine above, 3.8 kg of 5-p-fluorophenylhydantoin was used instead of 2.8 kg of 5-phenylhydantoin to finally obtain D-p-fluorobenzene with a purity of more than 99.8%. Glycine crystals 2.6kg.

采用与上述1D-对苯甘氨酸的制备相同的制备方法和参数,其中以5-对氯苯海因3.5kg代替5-苯海因2.8kg,最终得到纯度为99.8%以上的D-对氯苯甘氨酸晶体2.4kg。Using the same preparation method and parameters as the preparation of 1D-p-phenylglycine above, 3.5 kg of 5-p-chlorophenylhydantoin was used instead of 2.8 kg of 5-phenylhydantoin to finally obtain D-p-chlorobenzene with a purity of more than 99.8%. Glycine crystals 2.4kg.

采用与上述1D-对苯甘氨酸的制备相同的制备方法和参数,其中以5-对溴苯海因4.1kg代替5-苯海因2.8kg,最终得到纯度为99.8%以上的晶体D-对溴苯甘氨酸晶体2.9kg。Using the same preparation method and parameters as the preparation of 1D-p-phenylglycine above, 4.1 kg of 5-p-bromodihydantoin was used instead of 2.8 kg of 5-phenylhydantoin to finally obtain crystalline D-p-bromine with a purity of more than 99.8%. Phenylglycine crystals 2.9kg.

采用与实例二中1相同的制备方法和参数,其中以5-对碘苯海因2.8kg代替5-苯海因2.8kg,最终得到纯度为99.7%以上的D-对碘苯甘氨酸晶体2.1kg。Using the same preparation method and parameters as in Example 2, 2.8 kg of 5-phenylhydantoin was used instead of 2.8 kg of 5-phenylhydantoin to finally obtain 2.1 kg of D-iodophenylglycine crystals with a purity of more than 99.7%. .

3、D-3-吡啶甘氨酸的制备3. Preparation of D-3-pyridine glycine

在50L的酶催化反应罐中,先加入32kg水,在搅拌的条件下投入5-(3-吡啶基)海因3.8kg,加盐酸或硫酸调整pH为6.3,再加入由实施例一中1制备的湿的海因酶制剂1.8kg和实施例一中2制备的湿的氨甲酰水解酶酶制剂3.0kg,混合均匀,于33℃下搅拌反应。In a 50L enzyme-catalyzed reaction tank, first add 32kg of water, drop 3.8kg of 5-(3-pyridyl)hydantoin under stirring conditions, add hydrochloric acid or sulfuric acid to adjust the pH to 6.3, and then add 1 Prepared 1.8 kg of wet hydantoin enzyme preparation and 3.0 kg of wet carbamoylase enzyme preparation prepared in 2 of Example 1, mixed uniformly, and stirred and reacted at 33°C.

当反应进行到6h左右时,则有D-3-吡啶甘氨酸晶体开始析出,然后定期取样并用高效液相色谱检测反应,待液相色谱几乎检不出底物5-(3-吡啶基)海因,且中间体N-氨甲酰-3-吡啶甘氨酸含量低于0.20%(w/w)时,停止反应。5-(3-吡啶基)海因的转化率在99.6%以上。When the reaction was carried out to about 6h, D-3-pyridine glycine crystals began to separate out, and then samples were taken regularly and the reaction was detected by high performance liquid chromatography, and the substrate 5-(3-pyridyl) seawater was hardly detected by liquid chromatography. Therefore, and when the content of the intermediate N-carbamoyl-3-pyridine glycine is lower than 0.20% (w/w), the reaction is stopped. The conversion rate of 5-(3-pyridyl)hydantoin is above 99.6%.

反应混合物经200目筛以实现固体产物与菌体和溶液之间的分离,得到D-3-吡啶甘氨酸的粗晶体,以水为溶剂,通过酸碱转化重结晶便可获得D-3-吡啶甘氨酸1.87kg,此为第一部分产品;将透过筛的得到的液体进一步提取:首先将液体通过截留1万分子量的超滤膜进行过滤,滤液经减压蒸发浓缩,期间有D-3-吡啶甘氨酸结晶析出。过滤收集D-3-吡啶甘氨酸结晶,再采用第一部分产品相同的重结晶方法,便可获得第二部分产品0.81kg。合并两部分D-3-吡啶甘氨酸,共得纯度为99.2%以上、质量为2.68kg的产品,总收率82%。The reaction mixture is sieved through 200 mesh to separate the solid product from the bacteria and the solution, and the crude crystal of D-3-pyridine glycine is obtained. Using water as the solvent, D-3-pyridine can be obtained by recrystallization through acid-base conversion Glycine 1.87kg, this is the first part of the product; the liquid obtained through the sieve is further extracted: firstly, the liquid is filtered through an ultrafiltration membrane with a molecular weight cut-off of 10,000, and the filtrate is evaporated and concentrated under reduced pressure, during which there is D-3-pyridine Glycine crystallized out. Collect the crystals of D-3-pyridineglycine by filtration, and then use the same recrystallization method as the first part of the product to obtain the second part of product 0.81kg. The two parts of D-3-pyridineglycine were combined to obtain a product with a purity of more than 99.2% and a mass of 2.68 kg, with a total yield of 82%.

4、D-2-萘甘氨酸的制备4. Preparation of D-2-naphthylglycine

在50L的酶催化反应罐中,先加入37kg水,在搅拌的条件下投入5-(2-萘基)海因3.8kg,加盐酸或硫酸调整pH为7.1,再加入由实施例一/1制备的湿的海因酶制剂1.5kg和实施例一中2制备的湿的氨甲酰水解酶酶制剂2.3kg,混合均匀,于38℃下搅拌反应。In a 50L enzyme-catalyzed reaction tank, first add 37kg of water, drop in 3.8kg of 5-(2-naphthyl)hydantoin under stirring conditions, add hydrochloric acid or sulfuric acid to adjust the pH to 7.1, and then add the Prepared 1.5 kg of wet hydantoin enzyme preparation and 2.3 kg of wet carbamoylase enzyme preparation prepared in 2 of Example 1, mixed uniformly, and stirred and reacted at 38°C.

当反应进行到7h左右时,则有D-2-萘甘氨酸晶体开始析出,然后定期取样并用高效液相色谱检测反应,待液相色谱几乎检不出底物5-(2-萘基)海因及对应中间体时,停止反应。5-(2-萘基)海因的转化率在99.0%左右。When the reaction was carried out to about 7h, D-2-naphthylglycine crystals began to separate out, and then samples were taken regularly and the reaction was detected by high-performance liquid chromatography. The liquid chromatography was almost unable to detect the substrate 5-(2-naphthyl) seawater When the corresponding intermediate is reached, stop the reaction. The conversion rate of 5-(2-naphthyl)hydantoin is about 99.0%.

反应混合物过200目筛以实现固体产物与菌体细胞和溶液之间的分离,得到D-2-萘甘氨酸的粗晶体,以水为溶剂,通过酸碱转化重结晶得D-2-萘甘氨酸1.90kg,此为第一部分产品;将透过筛得到的部分液体进一步提取:首先将液体通过截留1万分子量的超滤膜进行过滤,滤液经减压蒸发浓缩,期间有D-2-萘甘氨酸结晶析出。过滤收集D-2-萘甘氨酸结晶,再采用第一部分产品相同的重结晶方法,便可获得第二部分产品0.63kg。合并两部分D-2-萘甘氨酸,共得纯度为98.8%以上、质量为2.53kg的产品,总收率75%。Pass the reaction mixture through a 200-mesh sieve to separate the solid product from the bacterial cells and the solution, and obtain the crude crystals of D-2-naphthylglycine. Using water as a solvent, recrystallize through acid-base conversion to obtain D-2-naphthylglycine 1.90kg, this is the first part of the product; part of the liquid obtained through the sieve is further extracted: first, the liquid is filtered through an ultrafiltration membrane with a molecular weight cut-off of 10,000, and the filtrate is evaporated and concentrated under reduced pressure, during which there is D-2-naphthylglycine Crystallized out. Collect D-2-naphthylglycine crystals by filtration, and then use the same recrystallization method as the first part of the product to obtain the second part of product 0.63kg. The two parts of D-2-naphthylglycine were combined to obtain a product with a purity of more than 98.8% and a mass of 2.53 kg, with a total yield of 75%.

5、D-2-喹啉甘氨酸的制备5. Preparation of D-2-quinoline glycine

在50L的酶催化反应罐中,先加入36kg水,在搅拌的条件下投入5-(2-喹啉基)海因4.2kg,调整pH为6.5,然后加入由实施例一中1制备的湿的海因酶制剂1.5kg和实施例一中2制备的湿的氨甲酰水解酶酶制剂3.2kg,混合均匀,于37℃下搅拌反应。In a 50L enzyme-catalyzed reaction tank, first add 36kg of water, put 4.2kg of 5-(2-quinolyl)hydantoin under stirring conditions, adjust the pH to 6.5, and then add the wet solution prepared by 1 in Example 1 1.5 kg of the hydantoin enzyme preparation and 3.2 kg of the wet carbamoylase enzyme preparation prepared in 2 in Example 1 were mixed uniformly, and stirred and reacted at 37° C.

当反应进行到6h左右时,则有D-2-喹啉甘氨酸晶体开始析出,然后定期取样并用高效液相色谱检测反应,待液相色谱几乎检不出底物5-(2-喹啉基)海因,且其中间体N-氨甲酰-D-喹啉甘氨酸在反应液中的含量低于0.3%(w/w)时,停止反应。5-(2-喹啉基)海因的转化率在99.5%左右。When the reaction was carried out to about 6h, D-2-quinoline glycine crystals began to separate out, and then samples were taken regularly and the reaction was detected by high performance liquid chromatography, and the substrate 5-(2-quinolyl) was hardly detected by liquid chromatography. ) Hydantoin, and when the content of its intermediate N-carbamoyl-D-quinoline glycine in the reaction solution is lower than 0.3% (w/w), the reaction is stopped. The conversion rate of 5-(2-quinolyl)hydantoin is about 99.5%.

反应混合物过200目筛以实现固体产物与菌体细胞和溶液之间的分离,得到D-2-喹啉甘氨酸的粗晶体。以水为溶剂,通过酸碱转化重结晶得D-2-喹啉甘氨酸2.55kg,此为第一部分产品;将透过筛得到的液体进一步提取:首先将液体通过截留2万分子量的超滤膜过滤,滤液经减压蒸发浓缩,期间有D-2-喹啉甘氨酸结晶析出,过滤、收集D-2-喹啉甘氨酸结晶。再采用第一部分产品相同的重结晶方法,便可获得第二部分产品0.63kg,经检测合格后,合并两部分D-2-喹啉甘氨酸,共得纯度为98.5%以上、质量为3.18kg的产品,总收率85%。The reaction mixture was passed through a 200-mesh sieve to separate the solid product from the bacterial cells and the solution to obtain crude crystals of D-2-quinolineglycine. Using water as a solvent, 2.55kg of D-2-quinolineglycine was obtained through acid-base conversion and recrystallization, which is the first part of the product; the liquid obtained through the sieve was further extracted: first, the liquid was passed through an ultrafiltration membrane with a molecular weight cut-off of 20,000 After filtering, the filtrate was evaporated and concentrated under reduced pressure, during which D-2-quinolineglycine crystals were precipitated, and the D-2-quinolineglycine crystals were collected by filtration. Using the same recrystallization method as the first part of the product, 0.63kg of the second part of the product can be obtained. After passing the test, the two parts of D-2-quinolineglycine are combined to obtain a total purity of more than 98.5% and a quality of 3.18kg. Product, total yield 85%.

Claims (7)

1.生物催化合成D-芳基甘氨酸的酶制剂,其特征是,它由产海因酶的黄金节杆菌的活化细胞和产氨甲酰水解酶的放射形土壤杆菌的活化细胞组成;  1. The enzyme preparation of biocatalytic synthesis of D-arylglycine is characterized in that it is composed of the activated cells of Arthrobacter aureus producing hydantoinase and the activated cells of Agrobacterium radiata producing carbamoylase; 所述的生物催化合成D-芳基甘氨酸的酶制剂的制备方法,它包括以下步骤:  The preparation method of the enzyme preparation of described biocatalytic synthesis D-arylglycine, it comprises the following steps: a.将产海因酶的黄金节杆菌接种于含玉米浆、糖蜜、氢氧化钠水溶液、氯化钠、2-硫尿嘧啶、硫酸镁、硫酸锰和磷酸氢二铵的液体培养基中,于30~34℃搅拌活化培养,其中,搅拌速度为60rpm;活化时间为12~18h;空气压力为0.18~0.23Mpa;空气流量为20~26L/h;反应釜压力为0.04~0.06Mpa;然后将该培养液用水溶性壳聚糖絮凝,过滤收获固形酶制剂1;  a. inoculate the Arthrobacter aureus producing hydantoinase in the liquid culture medium containing corn steep liquor, molasses, aqueous sodium hydroxide solution, sodium chloride, 2-thiouracil, magnesium sulfate, manganese sulfate and diammonium hydrogen phosphate, Stir and activate culture at 30-34°C, wherein the stirring speed is 60rpm; the activation time is 12-18h; the air pressure is 0.18-0.23Mpa; the air flow rate is 20-26L/h; the pressure of the reactor is 0.04-0.06Mpa; The culture solution is flocculated with water-soluble chitosan, and the solid enzyme preparation 1 is harvested by filtration; 所述液体培养基含玉米浆360~460重量份、糖蜜380~480重量份、质量浓度为25~35%的氢氧化钠水溶液15~25重量份、氯化钠40~60重量份、2-硫尿嘧啶27~37重量份硫酸镁8~10重量份、硫酸锰1.2~1.8重量份、和磷酸氢二铵3~4重量份,并加水定容至8000重量份;  The liquid medium contains 360-460 parts by weight of corn steep liquor, 380-480 parts by weight of molasses, 15-25 parts by weight of aqueous sodium hydroxide solution with a mass concentration of 25-35%, 40-60 parts by weight of sodium chloride, 2- 27-37 parts by weight of thiouracil, 8-10 parts by weight of magnesium sulfate, 1.2-1.8 parts by weight of manganese sulfate, and 3-4 parts by weight of diammonium hydrogen phosphate, and add water to make up to 8000 parts by weight; b.将产氨甲酰水解酶的放射形土壤杆菌接种于含玉米浆、葡萄糖、蛋白胨、氯化钠、硫酸锰、磷酸氢二铵和阿拉伯糖的液体培养基中,于32~38℃搅拌活化培养,其中搅拌速度为60rpm;活化时间为15~22h;空气压力为0.18~0.23Mpa;空气流量为18~22L/h;反应釜压力为0.04~0.06Mpa;在所述培养基中添加氢氧化钠调节pH为6.5~7.8,然后将该培养液用水溶性壳聚糖絮凝,过滤收获固形酶制剂2;  b. Inoculate Agrobacterium radiata producing carbamoylase in a liquid medium containing corn steep liquor, glucose, peptone, sodium chloride, manganese sulfate, diammonium hydrogen phosphate and arabinose, and stir at 32-38°C Activation culture, wherein the stirring speed is 60rpm; the activation time is 15-22h; the air pressure is 0.18-0.23Mpa; the air flow rate is 18-22L/h; the pressure of the reactor is 0.04-0.06Mpa; hydrogen is added to the medium Sodium oxide adjusts the pH to 6.5-7.8, then flocculates the culture solution with water-soluble chitosan, and filters to harvest the solid enzyme preparation 2; 所述液体培养基含玉米浆200~400重量份、葡萄糖180~260重量份、蛋白胨80~100重量份、25g氯化钠20~30重量份、硫酸锰1.6~2.0重量份、磷酸氢二铵6.8~7.6重量份、和阿拉伯糖12~16重量份;并将所述液体培养基加水定容至8000重量份;  The liquid medium contains 200-400 parts by weight of corn steep liquor, 180-260 parts by weight of glucose, 80-100 parts by weight of peptone, 20-30 parts by weight of 25g sodium chloride, 1.6-2.0 parts by weight of manganese sulfate, diammonium hydrogen phosphate 6.8 to 7.6 parts by weight, and 12 to 16 parts by weight of arabinose; and adding water to the liquid medium to make up to 8000 parts by weight; c.将步骤a制得的固形酶制剂1和步骤b制得的固形酶制剂2混合,制得生物催化合成D-芳基甘氨酸的酶制剂,其中所述固形酶制剂1和所述固形酶制剂2的重量配比为1~5∶1~50。  c. Mix the solid enzyme preparation 1 prepared in step a with the solid enzyme preparation 2 prepared in step b to prepare an enzyme preparation for biocatalytically synthesizing D-arylglycine, wherein the solid enzyme preparation 1 and the solid enzyme preparation The weight ratio of preparation 2 is 1-5:1-50. the 2.如权利要求1所述的生物催化合成D-芳基甘氨酸的酶制剂,其特征是,所述黄金节杆菌产生的海因酶的初始酶活性为大于0.32U,所述放射形土壤杆菌产生的氨甲酰水解酶的初始的活性大于10U。  2. the enzyme preparation of biocatalytic synthesis D-arylglycine as claimed in claim 1, is characterized in that, the initial enzymatic activity of the hydantoin enzyme that described Arthrobacter aureus produces is greater than 0.32U, and described Agrobacterium radialis The initial activity of the carbamoylase produced was greater than 10U. the 3.如权利要求1所述的生物催化合成D-芳基甘氨酸的酶制剂,其特征是,所述黄金节杆菌的初始海因酶活性为0.32U~0.45U。  3. The enzyme preparation for biocatalytically synthesizing D-arylglycine according to claim 1, characterized in that the initial hydantoinase activity of Arthrobacter aureus is 0.32U-0.45U. the 4.如权利要求1所述的生物催化合成D-芳基甘氨酸的酶制剂,其特征是,所述黄金节杆菌为黄金节杆菌3256活化细胞,所述放射形土壤杆菌为放射形土壤杆菌3255活化细胞。  4. the enzyme preparation of biocatalytic synthesis D-arylglycine as claimed in claim 1, it is characterized in that, described Arthrobacter aureus is Arthrobacter aureus 3256 activated cell, and described Agrobacterium radialis is Agrobacterium radialis 3255 activate cells. the 5.如权利要求1所述的生物催化合成D-芳基甘氨酸的酶制剂,其特征是,所述的酶制剂用于酶催化非均相水解海因合成D-芳基甘氨酸;  5. the enzyme preparation of biocatalytic synthesis D-arylglycine as claimed in claim 1, is characterized in that, described enzyme preparation is used for enzyme catalyzed heterogeneous phase hydrolysis hydantoin synthetic D-arylglycine; 所述的酶催化非均相水解海因合成D-芳基甘氨酸的方法包括以下步骤:  The method for the synthesis of D-arylglycine by the enzyme-catalyzed heterogeneous hydrolysis hydantoin comprises the following steps: ①在酶催化反应罐中,加入水和5-芳基海因,并调整pH值为6.5~7.8,5-芳基海因的加入量占水和5-芳基海因总质量的比为5~21%,得混合溶液;  ①Add water and 5-arylhydantoin to the enzyme-catalyzed reaction tank, and adjust the pH value to 6.5-7.8. The ratio of the amount of 5-arylhydantoin to the total mass of water and 5-arylhydantoin is 5~21%, get mixed solution; ②在搅拌的条件下向酶催化反应罐中加入权利要求1~5任一所述的酶制剂,在25~40℃下搅拌反应,直至无法检测出5-芳基海因,制得D-芳基甘氨酸;所述酶制剂占步骤①中的混合溶液的总重量的1~10%,反应时间8~66小时;  ②Add the enzyme preparation according to any one of claims 1 to 5 into the enzyme-catalyzed reaction tank under stirring conditions, and stir the reaction at 25-40°C until 5-arylhydantoin cannot be detected to obtain D- Arylglycine; the enzyme preparation accounts for 1-10% of the total weight of the mixed solution in step ①, and the reaction time is 8-66 hours; ③通过200目筛分离沉淀出D-芳基甘氨酸固体,经过重结晶,获得D-芳基甘氨酸晶体。  ③ Separating and precipitating the D-arylglycine solid through a 200-mesh sieve, and obtaining D-arylglycine crystals through recrystallization. the 6.如权利要求1所述的生物催化合成D-芳基甘氨酸的酶制剂,其特征 是,所述D-芳基甘氨酸为D-苯甘氨酸、D-对羟基苯甘氨酸、D-氟苯甘氨酸、D-氯苯甘氨酸、D-溴苯甘氨酸、D-碘苯甘氨酸、D-甲氧苯甘氨酸、D-吡啶系列甘氨酸、D-萘系列甘氨酸、D-喹啉系列甘氨酸D-嘧啶甘氨酸、D-吡嗪甘氨酸、D-哒嗪甘氨酸、D-吲哚甘氨酸、D-噻吩甘氨酸、D-呋喃甘氨酸、D-吡咯甘氨酸、D-吡唑甘氨酸、D-咪唑甘氨酸、D-噻唑甘氨酸、D-噁唑甘氨酸和D-异噁唑甘氨酸中的一种。  6. the enzyme preparation of biocatalytic synthesis D-arylglycine as claimed in claim 1, is characterized in that, described D-arylglycine is D-phenylglycine, D-p-hydroxyphenylglycine, D-fluorophenylglycine , D-chlorophenylglycine, D-bromophenylglycine, D-iodophenylglycine, D-methoxyphenylglycine, D-pyridine series glycine, D-naphthalene series glycine, D-quinoline series glycine D-pyrimidine glycine, D -Pyrazine glycine, D-pyridazine glycine, D-indole glycine, D-thiophene glycine, D-furan glycine, D-pyrrole glycine, D-pyrazole glycine, D-imidazole glycine, D-thiazole glycine, D- One of oxazole glycine and D-isoxazole glycine. the 7.如权利要求6所述的生物催化合成D-芳基甘氨酸的酶制剂,其特征是,所述D-芳基甘氨酸为D-苯甘氨酸,所述D-苯甘氨酸的制备方法为:  7. the enzyme preparation of biocatalytic synthesis D-arylglycine as claimed in claim 6, is characterized in that, described D-arylglycine is D-phenylglycine, and the preparation method of described D-phenylglycine is: ①在酶催化反应罐中,加入水30kg和5-苯基海因2.8kg,并调整pH值为6.8;  ①In the enzyme-catalyzed reaction tank, add 30kg of water and 2.8kg of 5-phenylhydantoin, and adjust the pH value to 6.8; ②在搅拌的条件下向酶催化反应罐加入权利要求1-5之任一所述的生物催化合成D-芳基甘氨酸的酶制剂2.8kg,在38℃下搅拌反应,直至无法检测出5-苯基海因,并且中间产物N-氨甲酰苯甘氨酸含量按质量比小于等于0.25%,制得D-苯基甘氨酸;  2. Add 2.8kg of the enzyme preparation for biocatalytic synthesis of D-arylglycine according to any one of claims 1-5 to the enzyme catalytic reaction tank under stirring conditions, and stir and react at 38°C until 5-arylglycine cannot be detected. Phenylhydantoin, and the content of the intermediate product N-carbamoylphenylglycine is less than or equal to 0.25% by mass ratio to obtain D-phenylglycine; ③分离沉淀出D-苯基甘氨酸固体,经过重结晶,获得D-苯基甘氨酸晶体;  ③ Separation and precipitation of D-phenylglycine solid, after recrystallization, D-phenylglycine crystals were obtained; ④通过超滤膜过滤和蒸发浓缩来提取酶催化反应罐中溶液部分溶解的D-苯基甘氨酸,得D-苯基甘氨酸。  ④ Extract D-phenylglycine partially dissolved in the solution in the enzyme-catalyzed reaction tank through ultrafiltration membrane filtration and evaporation concentration to obtain D-phenylglycine. the
CN2010101813858A 2010-05-25 2010-05-25 Enzyme preparation for synthesizing D-aryl glycine through biocatalysis and preparation method and application thereof Active CN101906408B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010101813858A CN101906408B (en) 2010-05-25 2010-05-25 Enzyme preparation for synthesizing D-aryl glycine through biocatalysis and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010101813858A CN101906408B (en) 2010-05-25 2010-05-25 Enzyme preparation for synthesizing D-aryl glycine through biocatalysis and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN101906408A CN101906408A (en) 2010-12-08
CN101906408B true CN101906408B (en) 2013-04-17

Family

ID=43261995

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010101813858A Active CN101906408B (en) 2010-05-25 2010-05-25 Enzyme preparation for synthesizing D-aryl glycine through biocatalysis and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN101906408B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1928103A (en) * 2006-08-30 2007-03-14 石家庄经济技术开发区中天化工有限责任公司 Method of producing D-p-hydroxy-phenyl glycine by heterogeneous enzyme catalysis method
CN101104862A (en) * 2007-06-06 2008-01-16 河北科技大学 Synthesis of D-arylglycine by heterogeneous enzyme-catalyzed hydrolysis of 5-arylhydantoin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1928103A (en) * 2006-08-30 2007-03-14 石家庄经济技术开发区中天化工有限责任公司 Method of producing D-p-hydroxy-phenyl glycine by heterogeneous enzyme catalysis method
CN101104862A (en) * 2007-06-06 2008-01-16 河北科技大学 Synthesis of D-arylglycine by heterogeneous enzyme-catalyzed hydrolysis of 5-arylhydantoin

Also Published As

Publication number Publication date
CN101906408A (en) 2010-12-08

Similar Documents

Publication Publication Date Title
CN109504719B (en) Method for improving acid production rate and extraction rate of glutamic acid
CN107058416B (en) Fermentation process for refining glutamic acid
JP5455244B2 (en) Method for producing galactooligosaccharides by free cells
CN103320362B (en) One strain is produced the bacterial strain of L-Glutamic decarboxylase and is produced the method for γ-aminobutyric acid with it
CN109504720B (en) Green production process of glutamic acid
CN101748161A (en) Process for purifying succinic acid by anaerobic fermentation
CN101838672A (en) Method for producing gamma-amino butyric acid by using immobilized lactobacillus plantarum
CN104726510B (en) A kind of method of preparing lysine through fermentation
CN112195171A (en) Method for preparing beta-alanine by using immobilized enzyme
CN102766658A (en) Production process of Jew's ear melanin by fermentation and products of Jew's ear melanin
CN101260392A (en) A method for producing tannase by solid fermentation of Gallic gall raw material
CN101906408B (en) Enzyme preparation for synthesizing D-aryl glycine through biocatalysis and preparation method and application thereof
CN109266707B (en) Method for preparing polysialic acid
CN102703334A (en) Strain producing erythritol and method for producing erythritol by using strain
CN102533891A (en) Production method of lysine
CN104725258B (en) A kind of method of purification of lysine fermentation liquor
CN104673767A (en) Method for producing feruloyl esterase
CN116120214A (en) Method for extracting L-citrulline by utilizing chromatographic technique
CN103114122A (en) Method for preparing trans-4-aminomethyl-naphthenic acid from Actioplanes sp.
CN111235192B (en) Process for producing, separating and purifying L-phenylalanine
CN111004788B (en) A kind of pectin esterase and its preparation method and application
CN101104862B (en) Synthesis of D-arylglycine by heterogeneous enzyme-catalyzed hydrolysis of 5-arylhydantoin
CN103881946B (en) Rhodococcus fascians ZJB-1208 and the application in preparing 1-cyanocyclohexanoic yl acetamide thereof
KR100345847B1 (en) Method for producing cefazoline by immobilized enzyme
CN109576200A (en) A kind of recombinant bacterium producing glutamate racemase and its construction method and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant